Intel To Spend $11 Billion To Build New Manufacturing Facility In Israel
Intel is going to invest $11 billion dollars into a new manufacturing plant in Israel according to Israeli state sources. The Israeli government is expected to help Intel (NASDAQ:INTC) with a grant of some $1 billion USD, about 8 percent of what will be the ‘largest single investment ever made in Israel.’
The new project is expected to add 1,000 new employees to Intel’s workforce in the Southern region of Israel, adding to their nearly 13,000 employees in Israel, the state spokesman said.
While the California-headquartered chip maker has said it will “not publish details at this stage” regarding technical, or financial plans or a timeline for the project, Israeli media reported that it is planning to use its largest investment in Israel to date to construct a vast production facility in the southern city of Kiryat Gat.
Intel had previously requested the government cover 10 percent to 15 percent of the expected cost, but Israel offered a 5 percent grant with an additional 5 percent tax credit for a promise of jobs and at least a 12-year period of operation. Eventually, the two parties settled on and committed to an 8% contribution, according to Haaretz.
The maker of all things Core and Pentium is a major industrial exporter from Israel, hitting $4 billion in 2018, up $500 million from 2017.
Our continued confidence in Intel’s future and excellent partnership with the State of Israel is at the foundation of the business plan we will submit
– Yaniv Garty, Intel VP and Intel Israel general manager
It seems as though Intel is expecting a robust global semiconductor market for the next couple decades for such a significant expansion overseas. There are no details of the new facility, the technologies it will support, or the development timetable. We can only suspect that the plant will employ next-generation lithographic production techniques such as Intel’s long-delayed 10nm process and EUV-driven processes on down the line, namely 7nm and 5nm processes through 2030.